La Vida Verde, Inc. Signs Distribution Deal with Driven Deliveries
DENVER, CO / ACCESSWIRE / March 28, 2019 / International Cannabrands Inc. (CSE: JUJU) (the…
News
VistaGen Therapeutics Receives Australian Patent for Treatment of Depression with AV-101
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / VistaGen Therapeutics (NASDAQ: VTGN),…
GeneNews Launches First Telehealth Initiative for Patient Directed Testing
Company to Capitalize on $16.7 Billion Telehealth Market by Offering Patient Directed Testing Through an…
Oncolytics Biotech (R) Announces a Publication Highlighting Synergistic Effect of Pelareorep with a Proteasome Inhibitor in Preclinical Models of Multiple Myeloma
– Combination Synergistic Even in Cells That Have Developed Resistance to Bortezomib – Article Published…
Heat Biologics Reports 2018 Results and Provides Corporate Update
Recently announced interim HS-110 Phase 2 data demonstrating survival benefit in patients with ‘cold’ tumors…
Jaguar Health Issues Regulatory Update Regarding Potential Follow-on Indication for Mytesi
SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX)…
EVOTEC AG FISCAL YEAR 2018 RESULTS: ACCELERATED GROWTH AND STRONG LONG-TERM OUTLOOK
– EXCELLENCE IN SCIENCE, PARTNERED DRUG DISCOVERY & DEVELOPMENT, ACQUISITIONS, AND UNIQUE PLATFORM TECHNOLOGIES LEAD…
Resurrection of Emergent Health Corp. (EMGE: OTC Markets)
KING OF PRUSSIA, PA / ACCESSWIRE / March 27, 2019 / Emergent Health Corp. (the…
Easton Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division
TORONTO, ON / ACCESSWIRE / March 27, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH)…
Aytu BioScience Provides Study Update for Spermatogenesis Study of Natesto (R), the Only FDA-Approved, Nasally-Administered Testosterone Treatment
Interim Results Demonstrated Preservation of Sperm Parameters After Six Months of Treatment with Nasally-Administered Natesto…